Creative Medical Technology Holdings To Present ImmCelz® Subsidiary At World Stem Cell Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
2021 Honorees: NFL Alumni Health, the Klein Family), Feng Zhang, PhD and the Global Immunization Action Network Team (GIANT) and Joseph P. Vacanti, MD.
E-Mail
IMAGE: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam. view more
Credit: AlphaMed Press
Durham, NC Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in
STEM CELLS Translational Medicine.
In a randomized clinical trial at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, researchers investigated the safety and potential therapeutic value of administering bone marrow stromal stem cells to patients with Type 2 diabetes. In each case, the cells were autologous, or taken from the patients own bodies.
A study released in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection.
Share:
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ:LGVN) ( Longeveron or Company ), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announces it has been selected to present at the 2021 World Stem Cell Summit taking place virtually on June 14-18, in combination with the Wake Forest Institute for Regenerative Medicine (WFIRM) and Regenerative Medicine Foundation (RMF).
Dr. Joshua Hare, Co-Founder and Chief Science Officer, is scheduled to present in a session titled The Longevity Agenda: Canceling the Pathologies of Aging. Longeveron will also provide a pre-recorded 4-5 minute presentation as part of the Investment & Commercialization Forum Track of the Summit.